Large congenital melanocytic nevi (lCMN) are benign melanocytic tumors associated with an increased risk of melanoma transformation. They result predominantly from a post-zygotic somatic NRAS mutation. These lesions persist and even increase after birth proportionally to the child's growth. Therefore, we asked here whether cells with clonogenic and tumorigenic properties persisted postnatally in lCMN. Subpopulations of lCMN cells expressed stem cell/progenitor lineage markers such as Sox10, Nestin, Oct4, and ABCB5. In vitro, 1 in 250 cells from fresh lCMN formed colonies that could be passaged and harbored the same NRAS mutation as the original nevus. In vivo, lCMN specimens xenografted in immunocompromised mice expanded 4-fold. BrdU þ -proliferating and label-retaining melanocytes were found within the outgrowth skin tissue of these xenografts, which displayed the same benign nested architecture as the original nevus. lCMN cell suspensions were not able to expand when xenografted alone in Rag 2 À / À mice. Conversely, when mixed with keratinocytes, these cells reconstituted the architecture of the human nevus with its characteristic melanocyte layout, lentiginous hyperplasia, and nested architecture. Overall, our data demonstrate that, after birth, certain lCMN cell subtypes still display features such as clonogenic potential and expand into nevus-like structures when cooperating with adjacent keratinocytes.
INTRODUCTION
Congenital melanocytic nevi (CMN) are benign melanocytic tumors resulting from a neural crest-derived proliferation that can infiltrate the epidermis, dermis, and hypodermis. These nevi concern 1 in 20,000 births (Castilla et al., 1981) . They may have major medical and socio-aesthetic implications and moreover a risk toward melanoma transformation. Projected adult size remains the major criterion for classification (Krengel et al., 2013) . Large CMN (lCMN) are associated with a higher risk of melanoma (Marghoob et al., 1996; RuizMaldonado, 2004; Krengel et al., 2006) . Associated neurological abnormalities and tumors are also reported in these patients (Kinsler et al., 2013b) . Familial cases have rarely been reported (de Wijn et al., 2010) .
CMN are now considered to result predominantly from a post-zygotic somatic NRAS or BRAF mutation, both mutations being usually exclusive (Papp et al., 2005; Ichii-Nakato et al., 2006; Bauer et al., 2007; Kinsler et al., 2013b; Charbel et al., 2014) . Indeed, exome sequencing analysis conducted on lCMN samples by our group has shown that NRAS mutation was the sole recurrent somatic mutation identified and therefore sufficient to drive nevus development (Charbel et al., 2014) . Cutaneous melanocytic cells are primarily derived from the developing neural crest. In mouse, melanocytic precursor cells migrate in the dorsolateral pathway (Mackenzie et al., 1997; Jiao et al., 2006) . Migration then continues ventrally before the cells colonize the epidermis and developing hair follicles (Grichnik, 2008) .
Pathogenesis of nevi in humans remains uncompletely understood. It was suggested that nevi could arise from bulge melanocyte stem cells in mice (Krengel 2005; NishikawaTorikai et al., 2011; Tanimura et al., 2011) . Others have also shown that transformed nerve sheath stem cells may lead to formation of occult prenatal nevi (Cramer and Fesyuk, 2012) . Barnhill et al. have reported that embryonic stem cells from the neural crest may migrate along vessels and other tracks through angiotropism, resulting in the genesis of CMN (Barnhill et al., 2010) . However, such stem cell populations have not yet been isolated in humans. In CMN, the presence of a unique NRAS somatic mutation suggests that these tumors result from the development of a melanocytic clone. These cells then populate subcutaneous, dermal, and epidermal structures where they organize into a nevus (Grichnik, 2008) . The analysis of transgenic mice in which constitutively activated NRAS is restricted to the melanocyte lineage also supports this hypothesis. Indeed, these mice develop generalized, nevus-like dermal melanocytosis (Ackermann et al., 2005) . Altogether, these data support clonal proliferation in CMN. Of note, after birth, CMN increase in surface proportionally to the child's growth. Such evolution suggests postnatal potential for proliferation in CMN. Therefore, our study aimed at characterizing nevocytic cells capable of maintaining and propagating CMN.
RESULTS
Immunohistochemical and flow cytometric analyses indicate the presence of minor lCMN populations expressing stem cell markers lCMN (n ¼ 4 specimens) and superficial spreading melanoma (SSM; n ¼ 4) were compared ( Figure 1 ). The lesions were dissected in a gridded manner and various sectors analyzed per lesion: the number of positive cells was counted and reported to the total number of DAPI þ cells per percentage of total cells per 100 mm 2 surface areas, both in the epidermis and dermis (three per sector and per skin region).
The expression of melanocytic/melanoma marker such as MITF and HMB45 was first analyzed. MITF staining in the lesions demonstrated a higher level of differentiated melanocytic infiltrate in lCMN as compared with SSM ( Figure 1a ; lCMN mean ± SEM: 7.07 ± 0.51; ***Pp0.0001). Both SSM and lCMN harbored HMB45 þ cells; these cells were predominantly found in the epidermis and upper dermis in lCMN with a histochemical maturation (Supplementary Figure S1a online) .
Neural crest stem cell marker expression was then evaluated. Sox10, a key regulator of pigment cell formation, is expressed throughout all stages of melanocyte differentiation (Sommer, 2011) , as well as in CMN and melanoma (Shakhova et al., 2012) . Nestin is expressed in nevi and melanoma (Sharma et al., 2010) . In lCMN, Sox10 was predominantly expressed in the dermis. When compared with SSM, a significantly lower number of Sox10 þ cells was found in lCMN ( Figure 1b ; SSM mean ± SEM: 7.69 ± 0.75%; lCMN mean ± SEM: 5.34 ± 0.53%; *Pp0.05). The fact that lCMN harbor more MITF þ cells and less Sox10 þ cells compared with melanoma probably relates to a higher ratio of differentiated cells in nevi. Nestin was highly expressed both in lCMN and SSM without any statistical difference (Figure 1c) .
Oct4, an embryonic stem cell transcription factor mainly associated with an undifferentiated phenotype and adult germ cell tumors, may be expressed in the basal layer of human skin epidermis and in melanoma (Tai et al., 2005; Cheli et al., 2011) . Oct4-MelanA double stainings were performed.
Oct4
þ Melan-A þ cells were detected in both SSM and lCMN without any statistical difference (Figure 1d ).
Chemoresistance mediator ABCB5 is expressed in human malignant melanoma initiating cells (Schatton et al., 2008 ; Figure 1e ; SSM mean ± SEM: 33.64 ± 6.33%; lCMN mean ± SEM: 8.79 ± 1.23%; ***Pp0.0001). Expression of CD44, a well-accepted cancer stem cell surface marker, has been reported in benign and malignant melanocytic lesions (Leigh et al., 1996) . Here, benign lCMN as well as malignant SSM were featured by a similar CD44 expression (Supplementary Figure S1b online) .
As expected, the number of proliferating cells estimated through Ki67 labeling was strikingly lower in lCMN as compared with SSM ( Figure 1f ; SSM mean±SEM: 13.66±1.03%; lCMN mean±SEM: 8.64±0.69%; ***Pp0.0001). Of note, in lCMN, Ki67 expression was intense and localized mostly to the basal layer of the epidermis where melanocytes mainly reside usually within nevocytic nests, indicating a proliferative activity of melanocytes. This observation could possibly explain why lCMN have a higher risk of transformation compared with small congenital or acquired nevi.
In order to better evaluate the percentages of cells expressing stem cell markers in lCMN, FACS was performed on CD31
À CD45 À DAPI À sorted lCMN cell suspensions. Single-positive cells were present in these cell suspensions with 2.97% ABCB5 þ cells (Supplementary Figure S2a and Figure S2b online ). Neural crest nerve growth factor Receptor CD271 expressed by human neural crestderived tissues can characterize human melanoma-initiating cells (Boiko et al., 2010) . CD271 expression has not been previously reported in congenital nevi. In our study, 1.05% of lCMN cells were CD271 þ (Supplementary Figure S2a and b online). There was no co-expression of these stem cell markers. Altogether, these immunostainings and flow cytometric analyses demonstrate the presence within lCMN of cells expressing several stem cell markers, thus reflecting lCMN heterogeneity.
In vitro characteristics of spheroid colonies obtained from lCMN Non-adherent cell culture using optimized sphere medium was performed to better characterize the nevocytic cell suspensions. Sphere-forming and clonogenic assays allow evaluation of both cell self-renewal and differentiation at the single-cell level (Schatton et al., 2008; Pastrana et al., 2011) . Melanospheres generated from primary melanoma and melanoma cell lines have extensively been analyzed (Fang et al., 2005; Perego et al., 2010; Cheli et al., 2011) and served as controls in this study.
lCMN cell suspensions, primary melanoma cells, and Mel501 melanoma cells were cultured in three different optimized media: N2, B27, or B27 þ insulin (See Materials and Methods section for details). Primary and Mel501 melanoma cells and all lCMN cell suspensions (n ¼ 5) gave rise to spheroid colonies in the 3 media tested (Supplementary Figure  S3a To further assert the replicative abilities of CMN spheres, these were enzymatically dissociated on DIV13, replated de novo at very low density in optimized sphere medium, and studied over five passages in vitro. lCMN cells constantly formed spheres after each passage (Figure 2b ). A special care was given to cell digestion, absence of aggregation being constantly verified at each passage. Sphere number and diameter evaluated on DIV7 and 13 did not vary throughout the experiment (graphs in Figure 2b ). On DIV13, lCMN spheres expressed Melan-A as well as the stem cell markers Nestin and Oct-4 (Figure 2c ). Melan-A and/or Nestin expression was also found in all adherent cultured cells (Supplementary Figure S4a) , showing that in vitro culture allowed melanocyte selection. Of note, the percentages of Melan-A-positive cells were previously evaluated on DIV0 (at least 60% of Melan-A þ cells; Supplementary Figure S4b online). The percentage of lCMN cells giving rise to colonies was calculated using an in vitro limiting dilution assay (see Materials and Methods section and Liu et al., 2013) . The frequencies of cells displaying clonogenic potential were 1 in 302 cells on DIV7 and 1 in 254 cells on DIV13, respectively (n ¼ 3 specimens; Figure 3a) .
Soft agar colony formation assay that monitors anchorageindependent growth was used in order to confirm sphere clonality and assess anchorage-independent growth. On DIV 13, individually seeded lCMN cells were able to form colonies in soft agar only when cultured in optimized sphere medium (Supplementary Figure S4c online ; photomicrographs in Figure 3b ). Colony diameters measured 60-70 mm as in the classical sphere forming assay (n ¼ 5; graphs in Figure 2a and b, and 3b). Therefore, lCMN harbored cells capable of dividing and forming spheres, as well as soft agar colonies at a frequency of one in 250 cells.
Finally, the NRAS mutational status of these spheroid colonies was ascertained by pyrosequencing: NRAS exon 3 genotyping was performed on five lCMN specimens as well as on the in vitro colonies arising after adequate culture of the corresponding cell suspensions (Figure 3c ). The in vitro colonies always bore the same c.181C4A, p.Q61K or c.182A4G, p.Q61R NRAS mutation as the original nevus. Altogether, these data support the existence of NRAS-mutated cells capable of clonal proliferation within lCMN.
In vivo potential to induce benign tumors
In order to assess the tumorigenic potential of the nevocytic cells, xenotransplantations were performed using immunocompromised mice. Standardized specimens (3-mm punch biopsies) of lCMN were xenografted in brown adipose tissue in Rag2
À / À mice. Grafts were harvested 3 and 7 months post transplantation, and tumor volume was measured (n ¼ 8 grafted specimens; Figure 4a ). Seven months post grafting,
Clonogenic Cells in Large Congenital Nevi lCMN tissues had increased 4-fold when compared with the original biopsies (graph in Figure 4a ). Hematoxylin-eosin staining (Figure 4b ) revealed a xenograft architecture (''grafted nevus'') similar to the original nevus (''pregraft'') and a surrounding pigmented outgrowth tissue (''graft neoepi.'') enclosing a cystic structure. Anti-human Melan-A and antiSox10 labeling demonstrated in the grafted nevus as well as in the developing neoepidermis the presence of human C Charbel et al.
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Melan-A þ cells (Figure 4c ) and Sox10 þ cells (Figure 4d ) organized in melanocytic nests, thus reproducing the original nevus structure. Double labeling with anti-human Melan-A/ anti-BrdU or anti-Sox10/anti-BrdU antibodies was performed in mice that received a single BrdU injection 30 minutes before euthanasia (n ¼ 3 grafted specimens). In these grafted nevi, Melan-A þ /BrdU þ cells were present in both the grafted part of the nevus and neoepidermis (Figure 4e ). In another group of mice in which BrdU was injected 1 month before euthanasia, the presence of few human Sox10 þ /BrdU þ cells corresponding to Label-Retaining Cells (LRCs) could be confirmed (Figure 4f To fully determine the ability of these cells to reproduce a nevus, other transplantation experiments using lCMN suspensions were conducted. One million fresh nevocytic cell suspensions were mixed with Matrigel then grafted into the right flank of Rag2 À / À mice (n ¼ 5 injections from five specimens). Seven months post grafting, Matrigel was harvested. Inside the Matrigel, low numbers of DAPI þ cells and very few isolated human Melan-A and Sox-10 þ cells were still detectable (Figure 5a , white arrows), indicating the persistence of isolated long-term surviving human melanocytes. The absence of nevi development in Matrigel injected with nevocytes alone contrasted with the expanding grafted nevi. This strongly encouraged us to evaluate melanocytes' need for another cell type in order to expand--namely keratinocytes. To test this hypothesis, human non-tumorigenic keratinocytes (the HaCaT cell line) were mixed with the lCMN cell suspension in order to mimic the required physiological environment. Different concentrations of sorted CD31
À /CD45 À cell suspensions (1.5 million, 5,00,000 and 4,00,000 cells) were injected with HaCaT keratinocytes into Proliferative and clonogenic abilities of postnatal lCMN cells were then analyzed in vitro. We were able to demonstrate such features as lCMN cells were able to grow in spheres, could be passaged at least five times, and formed colonies in soft agar. Interestingly, nevocytic cell proliferation in sphere medium was significantly lower than that of their melanoma counterparts. Moreover, nevus spheres tended to reach a plateau in contrast with melanoma spheres, which grew permanently. Such kinetics may indicate that nevus cells have a limited ability to proliferate, followed by a possible ''quiescence or senescence'' phenomenon. Of note, the soft agar assays yielded colonies only when optimized sphere medium was used (Supplementary Figure S3d online ). There too, lCMN colony diameter remained unchanged between DIV7 and DIV13, whereas fully transformed Mel501 melanoma cells formed continuously growing colonies. Beyond clonality, growth in soft agar is usually considered as evidence for transformation. However, normal diploid cells such as articular chondrocytes are also capable of growth in soft agar without any transforming event (Skantze et al., 1985) . All these data indicate that lCMN contain cells that have the ability to grow clonally and give progeny in elective conditions and that appear to be partially transformed. Indeed, genotyping experiments showed that these cells harbored an NRAS mutation, similar to the one found in the original nevus. Overall, CMN colonies could be maintained for at least 84 days in vitro. Similarly, tumor-propagating cells have been reported in other benign cutaneous proliferations such as papilloma and hemangioma (Khan et al., 2008; Xu et al., 2011; Lapouge et al., 2012) . Beyond in vitro studies, maintaining properties were studied in vivo. Grafted biopsies from lCMN had expanded 4-fold in immunosuppressed mice after 7 months. This increase resulted from an outgrowth of additional nevus at the periphery of the graft. These results indicate that a population of ''committed'' propagating cells was responsible for the expansion of a nevus-like structure. The presence of labelretaining human melanocytes was found in the nevus outgrowth. Of note, Herlyn et al. grafted adult acquired nevi in mice, and persistence of melanocytes was found only before day 88 post grafting (Herlyn et al., 1986) , whereas this was constant after 7 months in our study. Herlyn's data together with ours suggest that long-standing tumorigenic cells are a privilege of lCMN, probably because of differences in mutational profile (Ichii-Nakato et al., 2006) . Indeed, NRAS mutation is a hallmark of lCMN as opposed to small/ intermediate CMN and acquired nevi that frequently harbor a BRAF mutation (Charbel et al., 2014) .
When seeded in Matrigel, melanoma cells are able to grow in immunosuppressed mice even when injected at low or very low numbers (Quintana et al., 2008; Boiko et al., 2010; Perego et al., 2010) . Applying this technique to lCMN cell suspension disclosed a significant difference: a small minority of cells from the initial nevi suspensions was able to persist after several months without evidence of proliferation. These cells appeared always as isolated and interspersed cells. The difference of behavior in Rag2 À / À mice between isolated melanocytes (in Matrigel) and nevus grafts prompted us to question cooperation between nevi melanocytes and keratinocytes. When a non-transformed human keratinocyte cell line was co-injected with lCMN cell suspension in Matrigel, a large and solid pigmented tumor developed. These specimens showed a multilayered pigmented epithelial structure containing proliferating melanocytes organized in melanocytic nests or in a lentiginous pattern. Therefore, lCMN contained cells capable of reconstituting a nevus-like structure when mixed with keratinocytes. These results are in accordance with an older study. The authors grafted on athymic mice a CMN coculture of epidermal cells, including melanocytes and keratinocytes, together with a fibroblast matrix. Up to 34 weeks, melanocytes were present only in a ''darkened'' epidermis without true nests. However, after this delay, the dermis presented many round multinucleated cells corresponding to CMN reconstitution (Cooper et al., 1999) . These results suggested that melanocytic nests originated in the epidermis and then migrated below. Our model of lCMN suspensions mixed with keratinocytes has shown that keratinocytes have a major role in melanocytic behavior in nevi, allowing the development and maintenance of melanocytic nests. Mediators of this cross talk remain to be determined. Keratinocytes control melanocyte migratory properties and dermal invasion potential by modulating E-cadherin expression (Gontier et al., 2002 (Gontier et al., , 2004 . Moreover, keratinocytes have a role in maintaining the melanocyte reservoir. The melanocyte stem cells reside in the hair follicle bulgesubbulge area, the lower permanent portion of the hair follicle, where they serve as a melanocyte reservoir for the skin and hair pigmentation. There, they directly adhere to hair follicle stem cells (Nishimura, 2011) . Forced expression of stem cell factor /KITL, which is constitutively expressed in the human epidermis, in the basal epidermis of mice using the Krt14 promoter allowed survival of melanocytes in mouse epidermis (Kunisada et al., 1998) . Certain inflammatory factors such as leukotriene C4 also induce chronic growth stimulation of human adult melanocytes (Medrano et al., 1993) . On the other hand, it has been shown that different fibroblast-secreted melanogenic peptides could modulate melanocyte numbers in monolayer cultures (Cario-André et al., 2006; Salducci et al., 2014) . In vitro results on monolayers and skin reconstructs, using growth factors and conditioned medium suggested that murine fibroblasts secrete soluble factors that can stimulate normal human melanocytes. Medium from human fibroblasts stressed by medium starvation could increase normal melanocyte proliferation in vitro. Moreover, among these growth factors, both human and murine stem cell factor induced an increase in melanocyte numbers (Cario-André et al., 2006) . Therefore, the role of fibroblasts as well as of other epithelial and hematopoietic cells as potential promoters of CMN tumor formation should also be investigated.
In conclusion, we demonstrated that lCMN contain a subpopulation of cells able to persist after birth, self-renew, and induce a nevus-like structure when cooperating with keratinocytes. This could explain nevus secondary resurgences, which have been described by surgeons following nevus excision, as well as the natural expansion of nevi during the child growth. On the other hand, the genomic analysis of these cells is in line with our previous report on the role of NRAS mutation as driver mutation in these benign melanocytic proliferations (Charbel et al., 2014) . Future studies should focus on better characterizing these lCMN propagating cells. Finally, a clinical valorization is expected, as the isolated cells could also serve as tools for drug screening in CMN and/or melanoma.
MATERIALS AND METHODS
Details can be found in Supplementary Materials and Methods online.
Human tissue samples
The study was approved by the institutional independent ethics committee (Comité de Protection des Personnes Ile de France Paris V) and complied with the Declaration of Helsinki principles. Patients and patients' guardians gave their written informed consent prior to participation. Human lCMN samples were obtained from the maxillofacial department of Armand Trousseau hospital. Seventeen patients with compound lCMN whose ages varied between 2 months and 5 years were included prospectively in the study on the basis of adequate clinical data. Classification was done using the projected adult size of the largest lesion (Krengel et al., 2013) . Four SSM from Tenon Hospital were used as positive controls.
Immunohistochemistry
Sections of 5-mm thickness were labeled with the following antibodies: anti-human MITF (1:250), anti-human Nestin (1:100), antihuman ABCB5 (1:50), anti-human KI67 (1:100), anti-human Oct4
